Korshunov A - Search Results

1

Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker.

Korshunov A, Okonechnikov K, Sahm F, Ryzhova M, Stichel D, Schrimpf D, Ghasemi DR, Pajtler KW, Antonelli M, Donofrio V, Mastronuzzi A, Rossi S, Camassei FD, Buccoliero AM, Haberler C, Slavc I, Dahiya S, Casalini B, Sievers P, Meyer J, Kumirova E, Zheludkova O, Golanov A, Jones DTW, Pfister SM, Kool M, von Deimling A. Korshunov A, et al. Acta Neuropathol. 2020 Mar;139(3):583-596. doi: 10.1007/s00401-019-02102-z. Epub 2019 Nov 28. Acta Neuropathol. 2020. PMID: 31781912

2

[An immunohistochemical study of tenascin expression in cerebellar medulloblastomas].

Korshunov AG, Golanov AV, Sycheva RV. Korshunov AG, et al. Zh Vopr Neirokhir Im N N Burdenko. 1997 Oct-Dec;(4):23-7. Zh Vopr Neirokhir Im N N Burdenko. 1997. PMID: 9460893 Russian.

3

[Immunohistochemical changes in apoptosis in glioblastoma of the cerebral hemispheres].

Korshunov AG, Sycheva RV, Golanov AV. Korshunov AG, et al. Arkh Patol. 1998 May-Jun;60(3):23-7. Arkh Patol. 1998. PMID: 9702296 Clinical Trial. Russian.

4

[Immunohistochemical study of neoplasm-associated proteins in cerebellum medulloblastomas].

Korshunov AG, Sycheva RV, Golanov AV. Korshunov AG, et al. Arkh Patol. 1998 Jul-Aug;60(4):8-14. Arkh Patol. 1998. PMID: 9791689 Russian.

5

Prognostic value of tumor-associated antigens immunoreactivity and apoptosis in medulloblastomas. An analysis of 73 cases.

Korshunov A, Golanov A, Ozerov S, Sycheva R. Korshunov A, et al. Brain Tumor Pathol. 1999;16(1):37-44. doi: 10.1007/BF02478900. Brain Tumor Pathol. 1999. PMID: 10532422

6

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases.

Korshunov A, Golanov A, Sycheva R, Pronin I. Korshunov A, et al. J Clin Pathol. 1999 Aug;52(8):574-80. doi: 10.1136/jcp.52.8.574. J Clin Pathol. 1999. PMID: 10645226 Free PMC article.

7

Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.

Korshunov A, Sycheva R, Timirgaz V, Golanov A. Korshunov A, et al. J Neurooncol. 1999;45(3):219-27. doi: 10.1023/a:1006369829576. J Neurooncol. 1999. PMID: 10845392

8

Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.

Korshunov A, Golanov A, Timirgaz V. Korshunov A, et al. J Neurol Sci. 2000 Aug 1;177(1):72-82. doi: 10.1016/s0022-510x(00)00347-6. J Neurol Sci. 2000. PMID: 10967185

9

The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.

Korshunov A, Golanov A. Korshunov A, et al. J Neurooncol. 2000 May;48(1):13-9. doi: 10.1023/a:1006475312401. J Neurooncol. 2000. PMID: 11026692

10

The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.

Korshunov A, Golanov A. Korshunov A, et al. Arch Pathol Lab Med. 2001 Jul;125(7):892-8. doi: 10.5858/2001-125-0892-TPSODT. Arch Pathol Lab Med. 2001. PMID: 11419973 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters